Full Access
The role of gene therapy in haemophilia
IAN PEAKE,
IAN PEAKE
Department of Medicine and Pharmacology, Royal Hallamshire Hospital, Sheffield
Search for more papers by this authorIAN PEAKE,
IAN PEAKE
Department of Medicine and Pharmacology, Royal Hallamshire Hospital, Sheffield
Search for more papers by this author
References
- 1 Hoeben RC., Fallaux FJ., van Tilburg NH., Cramer SJ., van Ormondt H., Briet E., van der Eb AJ.. Toward gene therapy for haemophilia A: long-term persistence of factor VIII-secreting fibroblasts after transplantation into immunodeficient mice. Human Gene Therapy, 1993; 4: 179–186.
- 2 Anson DS., Hock RA., Austen D., Smith KJ., Brownlee GG., Verma IM., Millar AD.. Towards gene therapy for haemophilia B. Molec Biol Med, 1987; 4: 11–20.
- 3 Armentano D., Thompson AR., Darlington G., Woo SLC.. Expression of human factor IX in rabbit hepatocytes by retrovirus-mediated gene transfer: potential for gene therapy of haemophilia B. Proc Nat Acad Sci USA, 1990; 87: 6141–6145.
- 4 Yao SN., Wilson JM., Nabel EG., Kurachi S., Hachiya HL., Kurachi K.. Expression of human factor IX in rat capillary endothelial cells: towards somatic gene therapy for hemophilia B. Proc Nat Acad Sci USA, 1991; 88: 8101–8105.
- 5 Dai Y., Roman M., Naviaux RK., Verma IM.. Gene therapy via primary myoblasts: long-term expression of factor IX protein following transplantation in vivo. Proc Nat Acad Sci USA, 1992; 89: 10892–10895.
- 6 Gerrard AJ., Hudson DL., Brownlee GG., Watt FM.. Towards gene therapy for haemophilia B using primary human keratinocytes. Nature Genetics, 1993; 3: 180–183.
- 7 St. Louis D., Verma IM.. An alternative approach to somatic cell gene therapy. Proc Nat Acad Sci USA, 1988; 85: 3150–3154.
- 8 Palmer TD., Thompson AR., Miller AD.. Production of human factor IX in animals by genetically modified skin fibroblasts. Potential therapy for hemophilia B. Blood, 1989; 73: 438–445.
- 9 Dai YF., Qiu XF., Xue JL., Hsueh JL., Liu ZD.. High efficient transfer and expression of human clotting factor IX cDNA in cultured human primary skin fibroblasts from haemophilia B patient by retroviral vectors. Science in China, Series B, 1992; 35: 183–193.
- 10 Axelrod JH., Read MS., Brinkhous KM., Verma IM.. Phenotypic correction of factor IX deficiency in skin fibroblasts of hemophilic dogs. Proc Nat Acad Sci USA, 1990; 87: 5173–5177.
- 11 Hoeben RC., Valerio D., van der Eb AJ., van Ormondt H.. Gene therapy for human inherited disorders: techniques and status. Crit Rev Oncol/Haemat, 1992; 13: 33–54.
- 12 Zhou JM., Qui XF., Lu DR., Lu JY., Xue JL.. Long-term expression of human factor IX cDNA in rabbits. Science in China, Series B, 1993; 36: 1333–1341.
- 13 Lu DR., Zhou JM., Zheng B., Qui XF., Xue JL., Wang JM., et al. Stage-1 clinical trial of gene therapy for haemophilia B. Science in China, Series B, 1993; 36: 1342–1351.
- 14 Kay MA., Rothenberg S., Landen CN., Bellinger DA., Leland F., Toman C., et al. In vivo gene therapy of haemophilia B: sustained partial correction in factor IX deficient dogs. Science, 1993; 262: 117–119.
- 15 Smith TAG., Mehaffey MG., Kayda DB., Saunders JM., Yei S., Trapnell BC., McClelland A., Kaleko M.. Adenovirus mediated expression of therapeutic plasma levels of human factor IX in mice. Nature Genetics, 1993; 5: 397–402.
- 16 Kotin RM., Siniscalco M., Samulski RJ., Zhu X., Hunter L., Laughlin CA., et al. Site specific integration by adenoassociated virus. Proc Nat Acad Sci USA, 1990; 87: 2211–2215.
- 17 Wolff JA., Malone RW., Williams P., Chang W., Acsadi G., Jani A., Felgner PL.. Direct gene transfer into mouse muscle in vivo. Science, 1990; 267: 1465–1468.
- 18 Wu CH., Wilson JM., Wu GY.. Targetting genes: delivery and persistent expression of a foreign gene driven by mammalian regulatory elements in vivo. J Biol Chem, 1989; 264: 16985–16987.
- 19 Cristiano RJ., Smith LC., Kay MA., Brinkley BR., Woo SLC.. Hepatic gene therapy: efficient gene delivery and expression in primary hepatocytes utilizing a conjugated adenovirus–DNA complex. Proc Nat Acad Sci USA, 1993; 90: 11548–11552.